Met Life Investment Management, LLC Alkermes Plc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

A detailed history of Met Life Investment Management, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 97,201 shares of ALKS stock, worth $2.68 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
97,201
Previous 85,701 13.42%
Holding current value
$2.68 Million
Previous $2.32 Million 0.99%
% of portfolio
0.01%
Previous 0.02%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$23.21 - $27.24 $266,915 - $313,260
11,500 Added 13.42%
97,201 $2.34 Million
Q1 2024

May 14, 2024
BUY
$26.4 - $32.56 $2.26 Million - $2.79 Million
85,701 New
85,701 $2.32 Million
Q3 2023

May 09, 2024
BUY
$27.17 - $31.97 $58,469 - $68,799
2,152 Added 2.52%
87,431 $2.45 Million
Q2 2023

Apr 29, 2024
BUY
$28.34 - $33.63 $2.48 Million - $2.94 Million
87,431 New
87,431 $2.74 Million
Q2 2023

Aug 10, 2023
BUY
$28.34 - $33.63 $60,987 - $72,371
2,152 Added 2.52%
87,431 $2.74 Million
Q1 2023

May 09, 2024
BUY
$25.31 - $29.02 $2.16 Million - $2.47 Million
85,279 New
85,279 $2.4 Billion
Q1 2023

May 15, 2023
BUY
$25.31 - $29.02 $2.16 Million - $2.47 Million
85,279 New
85,279 $2.4 Million
Q4 2022

Jun 14, 2023
BUY
$21.94 - $26.24 $31,505 - $37,680
1,436 Added 1.68%
86,715 $2.27 Billion
Q3 2022

May 10, 2024
BUY
$22.0 - $31.87 $48,004 - $69,540
2,182 Added 2.58%
86,715 $1.94 Million
Q3 2022

Jun 14, 2023
BUY
$22.0 - $31.87 $31,592 - $45,765
1,436 Added 1.68%
86,715 $1.94 Billion
Q2 2022

May 10, 2024
SELL
$26.4 - $30.54 $47,968 - $55,491
-1,817 Reduced 2.1%
84,533 $2.52 Million
Q2 2022

Jun 20, 2023
SELL
$26.4 - $30.54 $19,694 - $22,782
-746 Reduced 0.87%
84,533 $2.52 Billion
Q1 2022

May 10, 2024
BUY
$23.07 - $27.99 $1.99 Million - $2.42 Million
86,350 New
86,350 $2.27 Million
Q1 2022

Jun 20, 2023
BUY
$23.07 - $27.99 $24,707 - $29,977
1,071 Added 1.26%
86,350 $2.27 Billion
Q4 2021

Jun 21, 2023
SELL
$21.47 - $32.08 $597,037 - $892,080
-27,808 Reduced 32.61%
57,471 $1.34 Billion
Q3 2021

Jun 21, 2023
SELL
$23.37 - $32.13 $649,872 - $893,471
-27,808 Reduced 32.61%
57,471 $1.77 Billion
Q2 2021

May 17, 2024
SELL
$18.78 - $25.15 $530,159 - $709,984
-28,230 Reduced 32.94%
57,471 $1.41 Million
Q2 2021

Jun 21, 2023
SELL
$18.78 - $25.15 $522,234 - $699,371
-27,808 Reduced 32.61%
57,471 $1.41 Billion
Q1 2019

Jul 13, 2023
SELL
$28.4 - $36.49 $2.42 Million - $3.1 Million
-85,068 Reduced 99.75%
211 $7.7 Million
Q4 2018

Jul 13, 2023
SELL
$27.94 - $44.61 $2.38 Million - $3.79 Million
-85,069 Reduced 99.75%
210 $6.2 Million
Q3 2018

Jul 13, 2023
SELL
$38.6 - $46.12 $3.28 Million - $3.92 Million
-85,067 Reduced 99.75%
212 $9 Million

Others Institutions Holding ALKS

# of Institutions
346
Shares Held
183M
Call Options Held
209K
Put Options Held
89.4K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.52B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email